Skip to main content
. 2021 Aug 9;45(1):62–75. doi: 10.1007/s10865-021-00233-x

Table 2.

Mixed-effects models for the association of subjective sleep with next day cognitive functioning

Outcome Model Predictor B 95% CI p value Adj p value Overall P
Objective cognition
 Mobile color-word interference test (mCWIT), seconds to complete* 1 Subjective total sleep time .73 .73
2 Subjective sleep restfulness −.001 −.004, .002 .36
 Mobile verbal learning test (mVLT), total correct 3 Subjective total sleep time .65
4 Subjective sleep restfulness .082 −.046, .211 .21
Subjective cognition
 Forgetfulness Subjective total sleep time 0–3 .246 .125, .367  < .001  < .001
Subjective total sleep time 4–6 .066 .008, .125 .03 .051
Subjective total sleep time 8–10 −.048 −.110, .015 .13 .15
Subjective total sleep time 10 +  .140 −.050, .331 .15 .15  < .001
Total number of sleep meds .285 −.050, .619 .10
BDI-II .041 .026, .057  < .001
LT any substance use (ref. no) .173 −077, .422 .18
6 Subjective sleep restfulness −.011 −.022, −.001 .03 .03
Total number of sleep meds .272 −.063, .607 .12
BDI-II .041 .026, .057  < .001
LT any substance use (ref. no) .174 −.076, .424 .18
 Difficulty concentrating Subjective total sleep time 0–3 .288 .152, .424  < .001  < .001
Subjective total sleep time 4–6 .070 .004, .135 .04 .074
Subjective total sleep time 8–10 −.038 −.108, .031 .28 .37
Subjective total sleep time 10 +  .006 −.206, .219 .95 .95
Total number of sleep meds .348 .039, .656 .03  < 0.001
BDI-II .048 .034, .062  < .001
LT any substance use (ref. no) .223 −.007, .453 .06
8 Subjective sleep restfulness −.013 −.025, −.002 .02 .03
Total number of sleep meds .336 .029, .645 .04
BDI-II .047 .033, .062  < .001
LT any substance use (ref. no) .227 −.003, .0457 .06

Categorical subjective sleep predictors (i.e., Subjective total sleep time 0–3, etc.) and overall P presented only for significant Subjective total sleep outcomes (i.e., forgetful and difficulty concentrating); BDI-II = Beck Depression Inventory-Second Edition; HIV status, BDI-II total score, any lifetime substance use diagnosis and total number of sleep medications were included as covariates if p < .2 in the backwards model selection; LT = lifetime; Overall P = p-value for total sleep time; §reference group is Subjective total sleep time 6–8 h; *log10 transformed; Adj p-values are corrected for multiple testing with the Benjamini-Hochberg (BH) method (1) in comparisons of Subjective total sleep time 6–8 vs. the other sleep time groups; (2) in association analyses between the related outcomes (i.e., forgetfulness and difficulty concentrating) and Subjective sleep restfulness; significant associations (p < .05) are in bold